Futura Medical
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Fut… Read more
Futura Medical (FUM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: 0.384x
Based on the latest financial reports, Futura Medical (FUM) has a cash flow conversion efficiency ratio of 0.384x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX3.44 Million) by net assets (GBX8.96 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Futura Medical - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how Futura Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Futura Medical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Futura Medical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ZIWETO HOLDINGS LIMITED (USD)
SEM:ZWTO
|
N/A |
|
Macau Property Opportunities Fund Ltd
LSE:MPO
|
-0.003x |
|
Premier Exhibitions Inc
PINK:PRXIQ
|
-0.518x |
|
VietNam Holding Limited
LSE:VNH
|
0.084x |
|
Pacific Assets Trust plc
LSE:PAC
|
0.000x |
|
HITECH + DEVELOPMENT WIR.
F:858
|
N/A |
|
Al Arafa Investment And Consulting in EGP
EGX:AIVCB
|
N/A |
|
China Food and Beverage Company
PINK:CHIF
|
0.000x |
Annual Cash Flow Conversion Efficiency for Futura Medical (2001–2024)
The table below shows the annual cash flow conversion efficiency of Futura Medical from 2001 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX8.96 Million | GBX438.41K | 0.049x | -53.02% |
| 2023-12-31 | GBX5.48 Million | GBX570.25K | 0.104x | +108.51% |
| 2022-12-31 | GBX4.72 Million | GBX-5.78 Million | -1.224x | -207.24% |
| 2021-12-31 | GBX9.72 Million | GBX-3.87 Million | -0.398x | +92.52% |
| 2020-12-31 | GBX853.54K | GBX-4.54 Million | -5.323x | +95.71% |
| 2019-12-31 | GBX53.65K | GBX-6.66 Million | -124.063x | -23226.94% |
| 2018-12-31 | GBX8.85 Million | GBX-4.71 Million | -0.532x | -16.00% |
| 2017-12-31 | GBX9.11 Million | GBX-4.17 Million | -0.458x | -74.94% |
| 2016-12-31 | GBX12.58 Million | GBX-3.30 Million | -0.262x | +76.61% |
| 2015-12-31 | GBX4.79 Million | GBX-5.36 Million | -1.121x | -255.27% |
| 2014-12-31 | GBX9.72 Million | GBX-3.07 Million | -0.315x | +84.53% |
| 2013-12-31 | GBX987.77K | GBX-2.01 Million | -2.039x | -201.85% |
| 2012-12-31 | GBX2.87 Million | GBX-1.94 Million | -0.675x | -1.47% |
| 2011-12-31 | GBX2.76 Million | GBX-1.84 Million | -0.666x | +42.71% |
| 2010-12-31 | GBX901.00K | GBX-1.05 Million | -1.162x | -63.37% |
| 2009-12-31 | GBX1.85 Million | GBX-1.32 Million | -0.711x | +68.03% |
| 2008-12-31 | GBX886.00K | GBX-1.97 Million | -2.225x | -170.33% |
| 2007-12-31 | GBX2.77 Million | GBX-2.28 Million | -0.823x | -75.43% |
| 2006-12-31 | GBX3.95 Million | GBX-1.85 Million | -0.469x | +56.29% |
| 2005-12-31 | GBX1.98 Million | GBX-2.12 Million | -1.073x | -177.22% |
| 2004-12-31 | GBX3.75 Million | GBX-1.45 Million | -0.387x | +31.27% |
| 2003-12-31 | GBX2.41 Million | GBX-1.36 Million | -0.563x | +19.43% |
| 2003-01-31 | GBX1.52 Million | GBX-1.06 Million | -0.699x | -8.85% |
| 2002-01-31 | GBX2.00 Million | GBX-1.28 Million | -0.642x | -159.76% |
| 2001-01-31 | GBX-294.00K | GBX-316.00K | 1.075x | -- |